<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>NNN Buzz - Latest pharma stocks News &amp; Blogs</title>
    <link>https://www.nnnbuzz.com/topic/pharma%20stocks</link>
    <description>Stay updated with the latest pharma stocks articles, blogs, and stories from NNN Buzz</description>
    <language>en-US</language>
    <lastBuildDate>Sat, 23 May 2026 07:06:32 GMT</lastBuildDate>
    <managingEditor>admin@nnnbuzz.com (NNN Buzz)</managingEditor>
    <webMaster>admin@nnnbuzz.com (NNN Buzz)</webMaster>
    <ttl>15</ttl>
    <generator>Keynate Topic RSS Generator</generator>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.nnnbuzz.com/topic/pharma%20stocks/rss" rel="self" type="application/rss+xml" />
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.nnnbuzz.com/topic/pharma%20stocks" rel="alternate" type="text/html" />
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" rel="hub" href="https://pubsubhubbub.appspot.com/" />
    <image>
      <title>NNN Buzz - Latest pharma stocks News &amp; Blogs</title>
      <url>https://www.nnnbuzz.com/apple-touch-icon.png</url>
      <link>https://www.nnnbuzz.com/topic/pharma%20stocks</link>
      <width>96</width>
      <height>96</height>
    </image>
    <item>
      <title>Divi’s Laboratories Shares in Focus After Q4 FY26 Results; Board Recommends Rs 30 Final Dividend</title>
      <link>https://www.nnnbuzz.com/news/divi-s-laboratories-shares-in-focus-after-q-4-fy-26-results-board-recommends-rs-30-final-dividend</link>
      <description>&lt;a href="https://www.nnnbuzz.com/news/divi-s-laboratories-shares-in-focus-after-q-4-fy-26-results-board-recommends-rs-30-final-dividend"&gt;&lt;img alt="Divi’s Laboratories Shares in Focus After Q4 FY26 Results; Board Recommends Rs 30 Final Dividend" src="https://www.nnnbuzz.com/view/aman/untitled-design-17.jpg"&gt;&lt;/a&gt;&lt;p&gt;Divi’s Laboratories shares will be in focus after the company reported Q4 FY26 results with 13.4% YoY profit growth to ₹751 crore.&lt;/p&gt;</description>
      <category>ivis Laboratories Q4 results</category>
      <category>Divis Laboratories dividend</category>
      <category>Divis Laboratories share price</category>
      <category>Divis Labs Q4 FY26</category>
      <category>pharma stocks</category>
      <category>stock market news</category>
      <category>Divis Laboratories earnings</category>
      <category>dividend stocks India</category>
      <pubDate>Sat, 23 May 2026 07:06:32 GMT</pubDate>
      <guid>https://www.nnnbuzz.com/news/divi-s-laboratories-shares-in-focus-after-q-4-fy-26-results-board-recommends-rs-30-final-dividend</guid>
    </item>
  </channel>
</rss>
